Dinkelborg (27 résultats)

Etat : very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages.

Etat : Wie neu. 2004. 209 S. Alle Bücher & Medienartikel von Book Broker sind stets in gutem & sehr gutem gebrauchsfähigen Zustand. Dieser Artikel weist folgende Merkmale auf: Helle/saubere Seiten in fester Bindung. Sprache: Englisch Gewicht in Gramm: 524 Gebundene Ausgabe, Maße: 16 cm x 1.78 cm x 23.88 cm.…

gebundene Ausgabe, Leinen. with 20 Figures, 191 pages abgegriffen, abgerieben, sehr verschmutzt, fleckig, Kanten und Ecken bestossen, Seiten gebräunt, Stempel auf Titelblatt und Einbandinnenseite vorne, kein Schutzumschlag, mittlerer bis eher guter Zustand, in Englisch Sprache: Englisch Ernst Schering Research Foundation Workshop 48.…

Etat : Sehr gut. XIII, 191 Seiten. Mit 20 Figuren. Very good copy. ISBN: 3540201378 Sprache: Englisch Gewicht in Gramm: 990 8° (17,5-22,5 cm). Orig.-Pappband. [Hardcover / fest gebunden].

Etat : very_good. Gently read. May have name of previous ownership, or ex-library edition. Binding tight; spine straight and smooth, with no creasing; covers clean and crisp. Minimal signs of handling or shelving. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships USPS Media Mail.…

Hardcover 22x15. Etat : Gut. 191 Seiten gut bis sehr gut erhaltenes Exemplar, Buch ist noch verschweißt ha1006908 Sprache: Englisch Gewicht in Gramm: 450.

Etat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Because of the current progress in molecular medicine (genomics, proteomics), a plethora of new and often human-specific targets are being identified. These targets often play a significant role in the pathogenesis of diseases, and identifying them offers the potential for early diagnosis and intervention. An early in vivo validation of specific ligands binding to these targets in humans is needed to as­ sess their potential for targeted imaging and radiotherapy. Further- VI Preface more, such validation studies may allow for a better understanding of the molecular processes underlying phannacologic activity and therefore for a more successful development of phannaceuticals in general. The purpose of the Ernst Schering Research Foundation (ESRF) Workshop 48 was to provide a forum for an open exchange on the state of the art in the early development of such radiophanna­ ceuticals. Experts from academia, industry, and regulatory authori­ ties were invited to give presentations on aspects covering the identi­ fication of targets, preclinical studies on the safety of ligands, as well as their validation in human clinical trials. It was our intention to cover both the opportunities and the challenges that scientists in this field are facing. Radiopharmaceuticals are uniquely suitable for the above-men­ tioned target validation studies.…

Hardcover 22x15. Etat : Gut. 191 Seiten gut bis sehr gut erhaltenes Exemplar, Buch ist noch verschweißt ha1006883 Sprache: Englisch Gewicht in Gramm: 450.

Etat : New. In English.

Gebunden. Etat : New.

Etat : New. In English.

Taschenbuch. Etat : Neu. From Morphological Imaging to Molecular Targeting | Implications to Preclinical Development | Markus Schwaiger (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2013 | Springer | EAN 9783662073124 | Verantwortliche Person für die EU: Springer Nature Customer Service Center GmbH, Tiergartenstr. 17, 69121 Heidelberg, productsafety[at]springernature[dot]com | Anbieter: preigu.…

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Because of the current progress in molecular medicine (genomics, proteomics), a plethora of new and often human-specific targets are being identified. These targets often play a significant role in the pathogenesis of diseases, and identifying them offers the potential for early diagnosis and intervention. An early in vivo validation of specific ligands binding to these targets in humans is needed to as sess their potential for targeted imaging and radiotherapy. Further- VI Preface more, such validation studies may allow for a better understanding of the molecular processes underlying phannacologic activity and therefore for a more successful development of phannaceuticals in general. The purpose of the Ernst Schering Research Foundation (ESRF) Workshop 48 was to provide a forum for an open exchange on the state of the art in the early development of such radiophanna ceuticals. Experts from academia, industry, and regulatory authori ties were invited to give presentations on aspects covering the identi fication of targets, preclinical studies on the safety of ligands, as well as their validation in human clinical trials. It was our intention to cover both the opportunities and the challenges that scientists in this field are facing. Radiopharmaceuticals are uniquely suitable for the above-men tioned target validation studies.…

Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Because of the current progress in molecular medicine (genomics, proteomics), a plethora of new and often human-specific targets are being identified. These targets often play a significant role in the pathogenesis of diseases, and identifying them offers the potential for early diagnosis and intervention. An early in vivo validation of specific ligands binding to these targets in humans is needed to as sess their potential for targeted imaging and radiotherapy. Further- VI Preface more, such validation studies may allow for a better understanding of the molecular processes underlying phannacologic activity and therefore for a more successful development of phannaceuticals in general. The purpose of the Ernst Schering Research Foundation (ESRF) Workshop 48 was to provide a forum for an open exchange on the state of the art in the early development of such radiophanna ceuticals. Experts from academia, industry, and regulatory authori ties were invited to give presentations on aspects covering the identi fication of targets, preclinical studies on the safety of ligands, as well as their validation in human clinical trials. It was our intention to cover both the opportunities and the challenges that scientists in this field are facing. Radiopharmaceuticals are uniquely suitable for the above-men tioned target validation studies. …

Etat : New.

Etat : gut. 2004. From Morphological Imaging to Molecular Targeting. Implications to Preclinical Development. Edited by M. Schwaiger, L. Dinkelborg and H. Schweinfurth. (= Ernst Schering Research Foundation Workshop, Vol. 48). In deutscher Sprache. pages.

Etat : New. pp. 216.

Etat : New. pp. 212.

Paperback. Etat : Brand New. reprint edition. 216 pages. 8.27x5.83x0.51 inches. In Stock.

Hardcover. Etat : Brand New. 1st edition. 191 pages. 8.25x5.25x0.50 inches. In Stock.

Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Because of the current progress in molecular medicine (genomics, proteomics), a plethora of new and often human-specific targets are being identified. These targets often play a significant role in the pathogenesis of diseases, and identifying them offers the potential for early diagnosis and intervention. An early in vivo validation of specific ligands binding to these targets in humans is needed to as sess their potential for targeted imaging and radiotherapy. Further- VI Preface more, such validation studies may allow for a better understanding of the molecular processes underlying phannacologic activity and therefore for a more successful development of phannaceuticals in general. The purpose of the Ernst Schering Research Foundation (ESRF) Workshop 48 was to provide a forum for an open exchange on the state of the art in the early development of such radiophanna ceuticals. Experts from academia, industry, and regulatory authori ties were invited to give presentations on aspects covering the identi fication of targets, preclinical studies on the safety of ligands, as well as their validation in human clinical trials. It was our intention to cover both the opportunities and the challenges that scientists in this field are facing. Radiopharmaceuticals are uniquely suitable for the above-men tioned target validation studies. 212 pp. Englisch.…

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Because of the current progress in molecular medicine (genomics, proteomics), a plethora of new and often human-specific targets are being identified. These targets often play a significant role in the pathogenesis of diseases, and identifying them offers the potential for early diagnosis and intervention. An early in vivo validation of specific ligands binding to these targets in humans is needed to as sess their potential for targeted imaging and radiotherapy. Further- VI Preface more, such validation studies may allow for a better understanding of the molecular processes underlying phannacologic activity and therefore for a more successful development of phannaceuticals in general. The purpose of the Ernst Schering Research Foundation (ESRF) Workshop 48 was to provide a forum for an open exchange on the state of the art in the early development of such radiophanna ceuticals. Experts from academia, industry, and regulatory authori ties were invited to give presentations on aspects covering the identi fication of targets, preclinical studies on the safety of ligands, as well as their validation in human clinical trials. It was our intention to cover both the opportunities and the challenges that scientists in this field are facing. Radiopharmaceuticals are uniquely suitable for the above-men tioned target validation studies. 216 pp. Englisch.…

Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -1 Molecular Imaging: Dream or Reality .- 2 Target Discovery and Validation.- 3 Noninvasive Imaging in Drug Discovery and Development.- 4 Internal Dose Assessment - Extrapolation from Animal Species to the Human.- 5 PET for Drug Development.- 6 Future Directions in Molecular Imaging.- 7 Regulatory Implications - The EU Perspective.- 8 Nonclinical Development of Radiopharmaceuticals: Regulatory Considerations for the United States Food and Drug Administration.- 9 The Japanese Perspective on Radiopharmaceuticals.- Previous Volumes Published in This Series.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 212 pp. Englisch.…

Etat : New. Print on Demand pp. 212 26 Illus. (6 Col.).

Etat : New. Print on Demand pp. 216.

Etat : New. PRINT ON DEMAND pp. 212.

Etat : New. PRINT ON DEMAND pp. 216.